HPV-Associated Oral and Throat Cancer: What You Need to Know

Course Overview

What does this course tell?
(Please note that the following overview content is from the original platform)
Welcome to HPV-Associated Oral and Throat Cancers: What You Need to Know This course, offered by the Department of Otolaryngology – Head and Neck Surgery at the Icahn School of Medicine at Mount Sinai, is designed to inform primary care physicians and otolaryngologists (general and head and neck surgeons), as well as medical students, residents, nurses, physician assistants, medical assistants, about HPV-associated oral and throat cancers. It is also applicable to individuals who wish to broaden their knowledge and vernacular about this disease process, especially those who may have been diagnosed with HPV and/or HPV-associated oropharyngeal cancers. The course has been divided into four modules, each of which is followed by multiple choice questions to help attendees further understand this condition: Week 1 - CME Information, Accreditation and Introduction (2 min) Week 2 - Module 1: HPV-associated Throat Cancer: An Epidemic (11 min. + quiz) Week 3 - Module 2: HPV Risk Factors and Clinical Presentation (10 min. + quiz) Week 4 - Module 3: Management of HPV-associated Oropharyngeal Cancer (13 min. + quiz) Week 5 - Module 4: Prevention, Vaccination, and the Horizon (10 min. + quiz) The primary objective of this course is to provide physicians with a thorough understanding of how to better diagnose and treat patients who have HPV-related oral and throat cancers. Note: This course is no longer available for CME Credit. Please review the CME Information and Accreditation prior to proceeding with the course modules. Release Date: February 4, 2019 Expiration Date: February 4, 2021 Estimated Time to Complete: 1 hour CME Fee: $30 CME Credits Offered: 1.0 CME Reviewer: Marita S. Teng, MD How to Receive CME Credit: For physicians who are interested in earning CME credits and other allied health professions who wish to receive a Verification of Attendance certificate, you must: a. Complete Signature Track (details to follow after enrolling in this course) b. Complete registration process through the Icahn School of Medicine at Mount Sinai, CME Office using the following link: ?EID4177&P3000&CaseID78 (WARNING: This course is no longer available for CME Credit.) (You will be required to pay an additional non-refundable fee of $30.00 in addition to the $49.00 fee for signature track.) c. Email an attached copy of your Verified Certificate from Coursera to the CME office at the Icahn School of Medicine at [email protected] and request your CME certificate. d. You will be provided with the instructions for downloading your CME/CE certificate. Course Planners Lynette Bobbitt Lisa Chase Eric M. Genden, MD Jill Gregory Gale Justin Paul Lawrence Carter Lim Erik Popil

We considered the value of this course from many aspects, and finally summarized it for you from two aspects: skills and knowledge, and the people who benefit from it:
(Please note that our content is optimized through artificial intelligence tools and carefully reviewed by our editorial staff.)
What skills and knowledge will you acquire during this course?
During this course, participants will acquire the following skills and knowledge:
1. Understanding of HPV-associated oral and throat cancers: Participants will gain a comprehensive understanding of the disease process, including its prevalence and impact on public health.
2. Diagnosis and clinical presentation: Participants will learn about the risk factors associated with HPV-related oral and throat cancers, as well as the clinical presentation and symptoms of the disease.
3. Management and treatment: Participants will be equipped with knowledge on the management and treatment options available for HPV-associated oropharyngeal cancer, including surgical and non-surgical approaches.
4. Prevention and vaccination: Participants will learn about the importance of prevention strategies, such as HPV vaccination, in reducing the incidence of HPV-related oral and throat cancers.
5. Current research and future perspectives: Participants will gain insights into the latest advancements in the field and the potential future directions for the management and prevention of HPV-associated oral and throat cancers.
Who will benefit from this course?
The course on HPV-Associated Oral and Throat Cancer will benefit primary care physicians and otolaryngologists (general and head and neck surgeons) by providing them with a thorough understanding of how to diagnose and treat patients with HPV-related oral and throat cancers. It is also relevant for medical students, residents, nurses, physician assistants, and medical assistants who want to expand their knowledge and vocabulary about this disease process. Additionally, individuals who have been diagnosed with HPV and/or HPV-associated oropharyngeal cancers can benefit from this course as it will provide them with valuable information about their condition.